Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02943564
Recruitment Status : Completed
First Posted : October 24, 2016
Last Update Posted : February 27, 2019
Sponsor:
Information provided by (Responsible Party):
Naurex, Inc, an affiliate of Allergan plc

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 10, 2018
  Actual Study Completion Date : December 18, 2018